A detailed history of Gleason Group, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Gleason Group, Inc. holds 31 shares of ELV stock, worth $12,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 38 18.42%
Holding current value
$12,882
Previous $20,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$500.12 - $562.29 $3,500 - $3,936
-7 Reduced 18.42%
31 $16,000
Q2 2024

Jul 12, 2024

BUY
$497.49 - $547.8 $3,482 - $3,834
7 Added 22.58%
38 $20,000
Q3 2023

Oct 12, 2023

BUY
$414.13 - $475.93 $414 - $475
1 Added 3.33%
31 $13,000
Q2 2023

Jul 20, 2023

SELL
$436.33 - $496.2 $5,235 - $5,954
-12 Reduced 28.57%
30 $13,000
Q1 2023

Apr 14, 2023

SELL
$446.3 - $502.2 $892 - $1,004
-2 Reduced 4.55%
42 $19,000
Q3 2022

Oct 11, 2022

BUY
$445.98 - $507.0 $19,623 - $22,308
44 New
44 $20,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $99.7B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Gleason Group, Inc. Portfolio

Follow Gleason Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.